Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $9.68B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LQDA | LIQUIDIA CORP | $7.02B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $41.76B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.43B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $11.06B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $4.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $9.42B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $2.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $33.27B | 1.58% | 46.90% | $0.2350 | $0.91 | 36% | 0 | ||
| ADMA | ADMA BIOLOGICS INC | $2.07B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $826.43M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.28B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ASND | ASCENDIS PHARMA A | $17.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TGTX | TG THERAPEUTICS INC | $8.16B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.16B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LGND | LIGAND PHARMACEUTICALS INC | $6.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $11.09B | 0.45% | 45.10% | $0.0800 | $0.32 | 8% | 1 | ||
| SPRO | SPERO THERAPEUTICS INC | $127.38M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $14.04B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $134.02B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAGE | NIAGEN BIOSCIENCE INC | $273.18M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UTHR | UNITED THERAPEUTICS CORP | $23.60B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $68.59B | 0.56% | 8.40% | $0.9400 | $3.64 | 11% | 0 | ||
| VCYT | VERACYTE INC | $4.55B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $23.35B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SRPT | SAREPTA THERAPEUTICS INC | $2.04B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDXG | MIMEDX GROUP INC | $588.34M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.